Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Contents

For professionals · Chapter 1 of 12

The adult with recurrent inflammation

Start with the inflammatory pattern, its consequences and the dangerous alternatives. A recurrent fever is a problem to explain, not a diagnosis.

Open introductory chapter

On this page

Recognize the pattern

Autoinflammatory conditions involve dysregulated innate immune pathways. Some are inherited; others arise without a simple germline explanation or develop through acquired somatic variants. “Autoinflammatory” does not mean that infection, malignancy or adaptive immune disease has already been excluded.

Reconstruct the earliest symptoms, including childhood events, rather than recording only the age at diagnosis. Document attack duration, interval health, objective temperatures, rash photographs, serositis, arthritis, oral or genital ulcers, eye symptoms, hearing changes and family history. Ask whether inflammation persists between attacks. An absent family history does not exclude genetic disease.

Establish what is happening now

During an informative episode, consider CBC with differential, CRP/ESR, renal and liver tests and urinalysis; ferritin is useful when systemic hyperinflammation is suspected. Repeat selected measures between attacks. Add cultures, imaging, tissue sampling and organ-specific tests according to the clinical problem, not a universal fever panel.

Review medications, travel and exposures, immune status, recurrent infections and constitutional symptoms. In an older adult, macrocytosis or otherwise unexplained cytopenias should change the differential. Persistent focal pain, a new murmur, weight loss or an abnormal examination requires its own investigation.

Use evidence without diagnostic shortcuts

High ferritin, a positive genetic panel or improvement with glucocorticoids is not independently diagnostic. Classification criteria support a structured assessment but do not replace exclusion of important mimics. A variant of uncertain significance is not a molecular diagnosis. Nonspecific autoantibodies can coexist and should not by themselves settle the mechanism.

Order genetic testing when the phenotype and potential clinical consequences justify it. Select germline or somatic testing deliberately, document assay coverage, and obtain genetics or an autoinflammation-center interpretation when results and phenotype diverge.

Decide urgency before naming the syndrome

Shock, altered consciousness, hypoxemia, severe new chest or abdominal pain, new neurologic deficits, bleeding, rapidly falling blood counts or evolving organ dysfunction require urgent hospital assessment. Infection can coexist with a flare. If MAS/HLH is suspected, investigation and treatment planning proceed together; do not wait for every criterion to accumulate.

The next clinical decision is often practical: which episode to sample, which organ to protect and who will reassess the patient. Record a working diagnosis and its uncertainty, the expected trajectory, and what would trigger reconsideration.

A practical differential at the first visit

Pattern or clueCompeting explanationNext discriminating step
Persistent fever, focal pain or a new murmurEndocarditis, occult abscess, tuberculosis or another infectionExposure and medication history; targeted cultures and imaging. Obtain cultures before antibiotics when feasible, without delaying sepsis treatment.
Weight loss, enlarging nodes, splenomegaly or cytopeniasLymphoma, another hematologic malignancy, Castleman diseaseExamine nodes and spleen; review smear and trends; arrange appropriate imaging and tissue diagnosis. A steroid response does not exclude lymphoma.
Fever after a new prescription or supplementDrug fever or a systemic hypersensitivity reactionReconstruct the exposure timeline; assess rash, eosinophilia, liver and kidney injury. Stop a suspected culprit within a clinician-directed plan.
Regular mouth ulcers and infections with neutropeniaCyclic neutropeniaSerial differential counts across symptomatic and well periods, with hematology input; one normal count is insufficient.
Reported episodes without corroborated inflammationMeasurement problems or a noninflammatory cause; rarely factitious illnessVerify the pattern respectfully. Do not infer deception from negative tests or unexplained symptoms.
Late onset, steroid dependence and macrocytosisVEXAS or another clonal disorderEvaluate common causes of macrocytosis and consider hematology with targeted somatic UBA1 testing.

Start with CBC/differential, creatinine/eGFR, liver tests, CRP/ESR and urinalysis when indicated by the presentation. Add ferritin, triglycerides, fibrinogen and coagulation studies promptly when MAS/HLH is plausible. Blood cultures, HIV/TB testing, echocardiography, cross-sectional imaging and biopsy should answer a specific question; they are not an indiscriminate panel. ANA testing without a compatible connective-tissue phenotype can create incidental findings.

Capture an attack and its recovery

For a stable outpatient with a familiar, self-limited pattern, agree in advance how an attack will be documented. Standing laboratory orders can make sampling in the first 24–48 hours practical; specify which laboratory is open, who receives results and when the clinician will respond. This is a practical workflow, not a validated diagnostic time threshold. An emergency must not wait for the planned blood draw.

  • Record start and end, measured temperature, symptoms, rash photographs, possible triggers, medicines taken and missed work. Keep the well intervals in the record too.
  • Repeat selected inflammatory and renal measures when clinically well. Persistent CRP/SAA elevation changes the assessment even if the person feels better.
  • Choose a follow-up date and an escalation threshold rather than leaving the patient to collect episodes indefinitely.

The patient attack diary is a printable discussion aid; detailed patient chapters require a free account.

Where Eurofever/PRINTO helps—and where it does not

The 2019 Eurofever/PRINTO criteria standardize classification of FMF, CAPS, TRAPS, MKD and PFAPA. Their prerequisites include inflammatory-marker elevation with flares, consideration of confounding infection, cancer, autoimmunity and other immune defects, and at least six months of recurrent activity. They should not be used to postpone needed treatment for six months or as a rule-out test for a newly ill adult.

Genotype-plus-phenotype and clinical-only approaches are distinct. For example, confirmatory MEFV findings plus a compatible feature are treated differently from a single pathogenic allele or uncertain result. Classification performance in a selected registry does not equal diagnostic accuracy in every adult fever clinic. Review the original criteria and variant definitions when using them; document the actual clinical basis of the diagnosis. See genetics and syndrome comparison.

Sources and further reading

Clinical educational material. Apply current regional prescribing information and specialist judgment to the individual patient.

Rheumatology in Perspective · by Olga Goodman, MD · A RheumaView publication · 14 November 2026

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: Autoinflammatory conditions